Clonidine and the anti-parkinsonian response to l-dopa or piribedil
- 1 January 1976
- journal article
- research article
- Published by Elsevier in Neuropharmacology
- Vol. 15 (1) , 25-27
- https://doi.org/10.1016/0028-3908(76)90093-9
Abstract
No abstract availableThis publication has 18 references indexed in Scilit:
- Evidence for a central α-sympathomimetic action of Clonidine in the ratJournal of Pharmacy and Pharmacology, 1975
- The central modulatory effect of clonidine on the cardiodepressor reflex after suppression of synthesis and storage of noradrenalineEuropean Journal of Pharmacology, 1975
- Fusaric acid in Parkinson's diseaseNeurology, 1974
- Hypothalamic Releasing Factors and Parkinson DiseaseArchives of Neurology, 1974
- Blood pressure crisis following withdrawal of clonidine (Catapres, Catapresan), with special reference to arterial and urinary catecholamine levels, and suggestions for acute managementAmerican Heart Journal, 1973
- Dopamine and noradrenaline receptor stimulation: Reversal of reserpine-induced suppression of motor activityPsychopharmacology, 1973
- Differential effects of reserpine and alpha-methyl-p-tyrosine on norepinephrine and dopamine induced behavioral activityPsychopharmacology, 1973
- Evidence for a central activation of a vagal cardiodepressor reflex by clonidineEuropean Journal of Pharmacology, 1972
- Studies on the action of some psychoactive drugs on central noradrenaline neurones after inhibition of dopamine-β-hydroxylaseBrain Research, 1970
- Some central effects of diethyldithiocarbamate administered intraventricularly in ratsNeuropharmacology, 1970